Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer

✍ Scribed by Johnny Kao; Eric M. Genden; Vishal Gupta; Edelweiss L. Policarpio; Ryan J. Burri; Michael Rivera; Vivek Gurudutt; Peter M. Som; Marita Teng; Stuart H. Packer

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 362 KB
• Volume: 117
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/cncr.25374